Latest Thrombolysis Stories
Even when its clot-dissolving powers are removed, the stroke drug tPA can still protect brain cells from the loss of oxygen and glucose induced by a stroke.
The clot-busting medicine, tPA (tissue plasminogen activator), is safe to use in acute stroke patients already on the home blood thinner warfarin, according to researchers from Duke Clinical Research Institute (DCRI).
Researchers from the Duke Clinical Research Institute have ruled the clot-busting drug tPA (tissue plasminogen activator) safe for acute stroke patients on the home blood thinner warfarin.
Acute ischemic stroke patients taking the blood thinner warfarin can be treated safely with the clot-busting drug tissue plasminogen activator (tPA).
Higher volume endovascular stroke centers have faster times to treatment, higher reperfusion rates and higher rates of good clinical outcomes.
Pulmonary embolism -- the sudden blockage of an artery in the lung -- is estimated to cause over 100,000 deaths each year in the U.S.
Everyone is familiar with the pain of skinned knees.
By discovering how a blood clot-busting enzyme is switched on, researchers have unlocked a century-old atomic riddle that could lead to new treatments for clotting and bleeding disorders, and some cancers.
- A poem in which the author retracts something said in an earlier poem.